glp 1 comorbidities Long-term Success of GLP-1s Hinges on More Than Just a Prescription GLP-1 medications are powerful metabolic

That pattern suggests these addictions share a common biological driver, one we hadnt been able to see until a drug revealed it

Will side effects compound over time

It is majorly found circulating in the blood as GLP-1(7-36) amide that is produced primarily from three tissues of the human body: enteroendocrine L cells in the distal small bowel, cells in the pancreas, and the central nervous system ( Surprisingly, it took approximately 20 years from the discovery of GLP-1 to the authorized approval of worldwide utilized GLP-1 RAs

The global market for GLP-1 receptor agonists was valued at USD 53.46 billion in 2024 and is expected to grow to USD 156.71 billion by 2030 , reflecting a compound annual growth rate of 17.46% between 2025 and 2030